Llwytho...
Allogeneic transplant for chronic myeloid leukemia in 2010
Tyrosine kinase inhibitor (TKI) therapy has revolutionized the therapy of chronic myeloid Leukemia (CML). Thus, while in the near past allogeneic transplantation was the curative option for CML, imatinib, nilotinib, and dasatinib have pushed transplantation to the role of salvage therapy in CML. Sti...
Wedi'i Gadw mewn:
| Prif Awdur: | |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SAGE Publications
2010
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3573387/ https://ncbi.nlm.nih.gov/pubmed/23556067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620710388339 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|